Echocardiography, commonly referred to as cardiac ultrasound or an “echo”, generates visual images of the heart known as echocardiograms. This imaging technique is especially informative during the peripartum period, the time encompassing before, during, and immediately after pregnancy. Preeclampsia is associated with an increased risk of cardiovascular disease which can show up in an echo.
A study conducted at NYU Langone Hospital aimed to assess the impact of routine postpartum echocardiograms on the management of patients diagnosed with severe preeclampsia. Researchers compared two groups: those who received echocardiograms after delivery and those who did not. The researchers wanted to see if having an echocardiogram affected hospital stay length, use of diuretics, adjustments in antihypertensive medication, and readmission rates.
The study included 356 patients, with 145 undergoing postpartum echocardiograms. Findings showed that patients who received echocardiograms had longer hospital stays (median of 5 days compared to 4), were more likely to receive diuretics, and had increased adjustments in their antihypertensive medication dosage. These patients were also more likely to be readmitted.
Further analysis within the echocardiogram group revealed that those with abnormal echo results experienced even longer hospital stays and a greater likelihood of receiving diuretics. However, there was no significant difference in the adjustment of antihypertensive medications or readmission rates between those with normal and abnormal echo results.
The study suggests that echocardiograms are often ordered for patients displaying more severe symptoms of preeclampsia, rather than the echocardiograms themselves prompting changes in management.
Take Home Message: The results indicate that postpartum echocardiograms can help identify patients with severe preeclampsia who may benefit from more intensive management strategies. Future research is encouraged to focus on detailed analyses of cardiac structure and function in these patients, which would require a larger sample size to enhance findings.
Link: https://www.ajog.org/article/S0002-9378(24)00450-2/pdf
Citation: Kantorowska, A., Corbo, A. M., Akerman, M. B., Gubernikoff, G., Kinzler, W. L., Vintzileos, A. M., & Rekawek, P. (2024). The value of maternal echocardiography after delivery in patients with severe preeclampsia. American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/j.ajog.2024.03.021
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
We provide research grant funding to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy.
By Amanda Yang, MS Evidence-based healthcare comes from trustworthy research. Research is designed carefully, so that it can be repeated and tested by other scientists. Wrong information or bad data...
By Sig-Linda Jacobsen, MD Neurological symptoms are not uncommon in those who have preeclampsia. The most common symptom is severe headache. Some patients may also experience eclampsia, or seizu...
Summary by Jennifer Mitchell, MPH, PhD Preeclampsia is a serious condition that can happen during pregnancy and affects 2-8% of pregnancies around the world. It can cause health problems for both the...
By Julie Reynolds, MD and Laney Poye As the Foundation often shares, research shows that women with a history of preeclampsia are two to four times more likely to develop cardiovascular disease (CVD)...
While the Preeclampsia Foundation has been championing patient advocacy and representation for all families affected by hypertension in pregnancy throughout our 25 year history, we recognized the uniq...